Exact Mass: 391.2813416

Exact Mass Matches: 391.2813416

Found 162 metabolites which its exact mass value is equals to given mass value 391.2813416, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Heteratisine

Heteratisine

C22H33NO5 (391.23586080000007)


Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid

   

NCIOpen2_009385

17-[(Benzylamino)methyl]estra-1,3,5(10)-triene-3,17beta-diol

C26H33NO2 (391.25111580000004)


   

N-Stearoyltaurine

2-[(1-Oxooctadecyl)amino]ethanesulfonic acid

C20H41NO4S (391.2756146000001)


N-Stearoyltaurine, also known as N-octadecanoyltaurine, belongs to the class of organic compounds known as N-acyl amines. N-Acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Thus, N-stearoyltaurine is considered to be a fatty amide lipid molecule. N-Stearoyltaurine is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. Specifically, N-stearoyltaurine belongs to the N-acyl taurines (NATs) fatty acid amide class. NATs with chains ranging in length from C16 to C24 have been identified in mice brain, liver, and kidney tissues. NATs were found to be regulated by the integral membrane enzyme fatty acid amide hydrolase (FAAH) and activated calcium channels from the transient receptor potential (TRP) family such as TRPV1 and TRPV4 (PMID: 16866345).

   

N-Arachidonoyl Serine

3-hydroxy-2-(icosa-5,8,11,14-tetraenamido)propanoic acid

C23H37NO4 (391.27224420000005)


N-arachidonoyl serine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Serine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Serine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Serine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Myristoyl Tyrosine

3-(4-hydroxyphenyl)-2-tetradecanamidopropanoic acid

C23H37NO4 (391.27224420000005)


N-myristoyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Tyrosine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide

N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenimidate

C26H33NO2 (391.25111580000004)


   

17-(3-Pyridyl)-5,16-androstadien-3beta-acetate

17-(3-Pyridyl)-5,16-androstadien-3beta-acetic acid

C26H33NO2 (391.25111580000004)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors D000970 - Antineoplastic Agents

   

N-Hexadecyl-N,N-dimethyl-3-ammonio-1-propanesulfonate

N-Hexadecyl-N,N-dimethyl-3-ammonio-1-propanesulphonic acid

C21H45NO3S (391.311998)


   

3-O-Demethylfortimicin A

2-amino-N-(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2,5,6-trihydroxycyclohexyl)-N-methylacetamide

C16H33N5O6 (391.2430718)


   

2-[(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]acetic acid

2-[(3S,8R,9S,10R,13S,14S)-10,13-Dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl]acetic acid

C26H33NO2 (391.25111580000004)


   
   
   
   
   
   

Streptorubin B

Butyl-meta-cycloheptylprodiginine

C25H33N3O (391.26234880000004)


   
   
   
   

daphnoldine B|methyl (8aRS,9RS,10aRS,11RS)-2,3,4,5,6,7,8,8a,9,10-decahydro-11-(hydroxymethyl)-11-(3-hydroxypentyl)-2-methyl-1H-4,10a-methanopentaleno[1,6-cd]azonine-9-carboxylate

daphnoldine B|methyl (8aRS,9RS,10aRS,11RS)-2,3,4,5,6,7,8,8a,9,10-decahydro-11-(hydroxymethyl)-11-(3-hydroxypentyl)-2-methyl-1H-4,10a-methanopentaleno[1,6-cd]azonine-9-carboxylate

C23H37NO4 (391.27224420000005)


   

(17R,E)-2-hydroxy-4,6-dimethoxy-17-acetoxy-cyclopentadeca-1,3-diene[1,2-b]pyridine|patungensin

(17R,E)-2-hydroxy-4,6-dimethoxy-17-acetoxy-cyclopentadeca-1,3-diene[1,2-b]pyridine|patungensin

C22H33NO5 (391.23586080000007)


   

karasamine

karasamine

C23H37NO4 (391.27224420000005)


Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid

   

3-O-Demethylfortimicin A

3-O-Demethylfortimicin A

C16H33N5O6 (391.2430718)


   
   
   
   

Palvanil

Hexadecanamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-

C24H41NO3 (391.3086276)


   
   
   
   
   

8-butyl-10-[(Z)-[(5Z)-3-methoxy-5-pyrrol-2-ylidenepyrrol-2-ylidene]methyl]-11-azabicyclo[7.2.1]dodeca-1(12),9-diene

8-butyl-10-[(Z)-[(5Z)-3-methoxy-5-pyrrol-2-ylidenepyrrol-2-ylidene]methyl]-11-azabicyclo[7.2.1]dodeca-1(12),9-diene

C25H33N3O (391.26234880000004)


   
   

N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide

N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide

C26H33NO2 (391.25111580000004)


   

C22H33NO5_6,6,9a-Trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate

NCGC00380319-01_C22H33NO5_6,6,9a-Trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate

C22H33NO5 (391.23586080000007)


   

C22H33NO5_D-Valine, N-acetyl-, (5aS,9S,9aS)-1,3,4,5,5a,6,7,8,9,9a-decahydro-6,6,9a-trimethyl-3-oxonaphtho[1,2-c]furan-9-yl ester

NCGC00180281-02_C22H33NO5_D-Valine, N-acetyl-, (5aS,9S,9aS)-1,3,4,5,5a,6,7,8,9,9a-decahydro-6,6,9a-trimethyl-3-oxonaphtho[1,2-c]furan-9-yl ester

C22H33NO5 (391.23586080000007)


   

N-(3-hydroxytetradecanoyl)-L-phenylalanine

N-(3-hydroxytetradecanoyl)-L-phenylalanine

C23H37NO4 (391.27224420000005)


   
   

N-arachidonoyl D-serine

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-D-serine

C23H37NO4 (391.27224420000005)


   

N,N-(2,2-dihydroxy-ethyl)arachidonoylamide

N,N-(2,2-dihydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO3 (391.3086276)


   
   

Fenretinide

4-Hydroxyphenylretinamide

C26H33NO2 (391.25111580000004)


C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids D020011 - Protective Agents > D016588 - Anticarcinogenic Agents D000970 - Antineoplastic Agents

   

N-Arachidonoyl-L-Serine

N-[1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl]-L-serine

C23H37NO4 (391.27224420000005)


An N-acyl-amino acid resulting from the formal condensation of the carboxy group of arachidonic acid with the amino group of L-serine. It is an endocannabinoid-like lipid isolated from bovine brains.

   

EMA-6

N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-L-serine

C23H37NO4 (391.27224420000005)


   

15-HETE-Ala

N-(15S-hydroxy-5Z,8Z,11Z,13E-eicosatetraenoyl)-alanine

C23H37NO4 (391.27224420000005)


   

12-HETE-Ala

N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-alanine

C23H37NO4 (391.27224420000005)


   

NA 23:5;O3

N-(12S-hydroxy-5Z,8Z,10E,14Z-eicosatetraenoyl)-alanine

C23H37NO4 (391.27224420000005)


   

NA 24:4;O2

N,N-(2,2-dihydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO3 (391.3086276)


   

NAT 18:0

N-octadecanoyl-taurine

C20H41NO4S (391.2756146000001)


   

(+)-UH 232 maleate,cis-(+)-5-Methoxy-1-methyl-2-(di-N-propylamino)tetralinmaleate

(+)-UH 232 maleate,cis-(+)-5-Methoxy-1-methyl-2-(di-N-propylamino)tetralinmaleate

C22H33NO5 (391.23586080000007)


   

1-(1-Boc-4-piperidyl)-3-methylpyrazole-4-boronic Acid Pinacol Ester

1-(1-Boc-4-piperidyl)-3-methylpyrazole-4-boronic Acid Pinacol Ester

C20H34BN3O4 (391.26422340000005)


   

(R,R)-N-Benzyl-3,4-trans-(N-Boc)-diaminopyrrolidine

(R,R)-N-Benzyl-3,4-trans-(N-Boc)-diaminopyrrolidine

C21H33N3O4 (391.2470938000001)


   

5-[2-(PHENYLSULFONYL]VINYL]-3-[1-METHYLPYRROLIDIN-2(R)-YLMETHYL]-1H-INDOLEHYDROGENBROMIDE

5-[2-(PHENYLSULFONYL]VINYL]-3-[1-METHYLPYRROLIDIN-2(R)-YLMETHYL]-1H-INDOLEHYDROGENBROMIDE

C28H41N (391.32388260000005)


   

Octadecyltrimethylammonium bromide

Octadecyltrimethylammonium bromide

C21H46BrN (391.2813416)


   

TETRA-N-BUTYLAMMONIUM TRIFLUOROMETHANESULFONATE

TETRA-N-BUTYLAMMONIUM TRIFLUOROMETHANESULFONATE

C17H36F3NO3S (391.2367862000001)


   

Abiraterone acetate

Abiraterone acetate

C26H33NO2 (391.25111580000004)


A sterol ester obtained by formal condensation of the 3-hydroxy group of abiraterone with the carboxy group of acetic acid. A prodrug that is converted in vivo to abiraterone. Used for treatment of metastatic castrate-resistant prostate cancer. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors C471 - Enzyme Inhibitor > C147923 - CYP17A1 Inhibitor D000970 - Antineoplastic Agents

   
   

N^2^-[(2R)-2-{(1S)-1-[Formyl(hydroxy)amino]ethyl}-5-phenylpentanoyl]-N,3-dimethyl-L-valinamide

N^2^-[(2R)-2-{(1S)-1-[Formyl(hydroxy)amino]ethyl}-5-phenylpentanoyl]-N,3-dimethyl-L-valinamide

C21H33N3O4 (391.2470938000001)


   
   

17-[(Benzylamino)methyl]estra-1,3,5(10)-triene-3,17beta-diol

17-[(Benzylamino)methyl]estra-1,3,5(10)-triene-3,17beta-diol

C26H33NO2 (391.25111580000004)


   

N-[2-(3,4-Dihydroxyphenyl)ethyl]hexadecanamide

N-[2-(3,4-Dihydroxyphenyl)ethyl]hexadecanamide

C24H41NO3 (391.3086276)


   

(3R,6S,6aS,8S,9R,10S,11aS,12S)-1-ethyl-8,10-dimethoxy-3-methyltetradecahydro-1H-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocine-6,11a-diol

(3R,6S,6aS,8S,9R,10S,11aS,12S)-1-ethyl-8,10-dimethoxy-3-methyltetradecahydro-1H-3,6a,12-(epiethane[1,1,2]triyl)-7,9-methanonaphtho[2,3-b]azocine-6,11a-diol

C23H37NO4 (391.27224420000005)


   

3alpha,12alpha-Dihydroxy-5beta-cholanate

3alpha,12alpha-Dihydroxy-5beta-cholanate

C24H39O4- (391.2848194)


   

3alpha,7beta-Dihydroxy-5beta-cholan-24-Oate

3alpha,7beta-Dihydroxy-5beta-cholan-24-Oate

C24H39O4- (391.2848194)


   

Chenodeoxycholate anion

Chenodeoxycholate anion

C24H39O4- (391.2848194)


   

Hyodeoxycholate

Hyodeoxycholate

C24H39O4- (391.2848194)


A bile acid anion that is the conjugate base of hyodeoxycholic acid.

   

Murideoxycholate

Murideoxycholate

C24H39O4- (391.2848194)


A bile acid anion that is the conjugate base of murideoxycholic acid.

   

3beta,12alpha-Dihydroxy-5beta-cholan-24-oate

3beta,12alpha-Dihydroxy-5beta-cholan-24-oate

C24H39O4- (391.2848194)


A bile acid anion that is the conjugate base of 3beta,12alpha-dihydroxy-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group. The 3beta-hydroxy epimer of deoxycholate. It is the major microspecies at pH 7.3.

   

3beta,7alpha-Dihydroxy-5beta-cholan-24-oate

3beta,7alpha-Dihydroxy-5beta-cholan-24-oate

C24H39O4- (391.2848194)


A bile acid anion that is the conjugate base of 3beta,7alpha-dihydroxy-5beta-cholan-24-oic acid, obtained by deprotonation of the carboxy group. The 3beta-hydroxy epimer of chenodeoxycholate. It is the major microspecies at pH 7.3.

   

(6S)-5-[3-Methoxy-5-(1H-pyrrole-2-yl)-2H-pyrrole-2-ylidenemethyl]-6-butyl-2,4-heptano-1H-pyrrole

(6S)-5-[3-Methoxy-5-(1H-pyrrole-2-yl)-2H-pyrrole-2-ylidenemethyl]-6-butyl-2,4-heptano-1H-pyrrole

C25H33N3O (391.26234880000004)


   

(R)-2-Ethyl-13-[[3-methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene]methyl]-12-azabicyclo[9.2.1]tetradeca-11(14),13(1)-diene

(R)-2-Ethyl-13-[[3-methoxy-5-(1H-pyrrol-2-yl)-2H-pyrrol-2-ylidene]methyl]-12-azabicyclo[9.2.1]tetradeca-11(14),13(1)-diene

C25H33N3O (391.26234880000004)


   

20-Hydroxy-prefusarin (open ring form)

20-Hydroxy-prefusarin (open ring form)

C22H33NO5 (391.23586080000007)


   

(E)-3beta,14beta,21-trihydroxy-23-nor-5-beta-chol-20(22)-enate

(E)-3beta,14beta,21-trihydroxy-23-nor-5-beta-chol-20(22)-enate

C23H35O5- (391.248436)


   
   

Isoursodeoxycholate

Isoursodeoxycholate

C24H39O4- (391.2848194)


A steroid acid anion that is the conjugate base of isoursodeoxycholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

3alpha,12alpha-Dihydroxy-5alpha-cholan-24-oate

3alpha,12alpha-Dihydroxy-5alpha-cholan-24-oate

C24H39O4- (391.2848194)


   

1-(3-Carboxypropyl)-9-(dimethylamino)-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium

1-(3-Carboxypropyl)-9-(dimethylamino)-11,11-dimethyl-2,3,4,11-tetrahydronaphtho[2,3-g]quinolinium

C25H31N2O2+ (391.23854059999996)


   

(2S,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2S,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2470938000001)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

(2S,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2S,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2470938000001)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide

C21H33N3O4 (391.2470938000001)


   

(2R,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2R,3R,4S)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2470938000001)


   

(2R,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

(2R,3S,4R)-2-(hydroxymethyl)-4-[[(2-methoxy-1-oxoethyl)-propan-2-ylamino]methyl]-3-phenyl-N-propan-2-yl-1-azetidinecarboxamide

C21H33N3O4 (391.2470938000001)


   

(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid

(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid

C21H33N3O4 (391.2470938000001)


   

1-Methyl-5-[2-[methyl(1-phenylpropan-2-yl)amino]ethyl]-2-phenyl-4-propan-2-ylpyrazol-3-one

1-Methyl-5-[2-[methyl(1-phenylpropan-2-yl)amino]ethyl]-2-phenyl-4-propan-2-ylpyrazol-3-one

C25H33N3O (391.26234880000004)


   

(1S,2S,6S,9S,11R,14R,17S,18S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

(1S,2S,6S,9S,11R,14R,17S,18S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

C22H33NO5 (391.23586080000007)


   

(1S,2S,6S,9S,11R,14R,17S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

(1S,2S,6S,9S,11R,14R,17S,19S)-12-ethyl-9,19-dihydroxy-17-methoxy-14-methyl-5-oxa-12-azahexacyclo[8.7.2.12,6.01,11.03,9.014,18]icosan-4-one

C22H33NO5 (391.23586080000007)


   
   

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxyoctan-2-yl)hexadeca-4,7,10,13-tetraenamide

(4Z,7Z,10Z,13Z)-N-(1,3-dihydroxyoctan-2-yl)hexadeca-4,7,10,13-tetraenamide

C24H41NO3 (391.3086276)


   

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]hexadeca-7,10,13-trienamide

(7Z,10Z,13Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]hexadeca-7,10,13-trienamide

C24H41NO3 (391.3086276)


   

N-Stearoyltaurine

N-Stearoyltaurine

C20H41NO4S (391.2756146000001)


A fatty acid-taurine conjugate derived from stearic acid.

   
   

ursodeoxycholate

ursodeoxycholate

C24H39O4 (391.2848194)


A bile acid anion that is the conjugate base of ursodeoxycholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N,N-(2,2-dihydroxy-ethyl) arachidonoyl amine

N,N-(2,2-dihydroxy-ethyl) arachidonoyl amine

C24H41NO3 (391.3086276)


   

Allodeoxycholate

Allodeoxycholate

C24H39O4 (391.2848194)


A bile acid anion that is the conjugate base of allodeoxycholic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

ATTO 610-2(1+)

ATTO 610-2(1+)

C25H31N2O2 (391.23854059999996)


The cationic form of a fluorescent dye derived from a tetrahydronaphtho[2,3-g]quinoline.

   

Chenodeoxycholate

Chenodeoxycholate

C24H39O4 (391.2848194)


Conjugate base of chenodeoxycholic acid; major species at pH 7.3.

   

SPHP(20:1)

SPHP(m20:1)

C20H42NO4P (391.2851302000001)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   

NA-Ile 18:3(6Z,9Z,12Z)

NA-Ile 18:3(6Z,9Z,12Z)

C24H41NO3 (391.3086276)


   

NA-Ile 18:3(9Z,12Z,15Z)

NA-Ile 18:3(9Z,12Z,15Z)

C24H41NO3 (391.3086276)


   

NA-Leu 18:3(6Z,9Z,12Z)

NA-Leu 18:3(6Z,9Z,12Z)

C24H41NO3 (391.3086276)


   

NA-Leu 18:3(9Z,12Z,15Z)

NA-Leu 18:3(9Z,12Z,15Z)

C24H41NO3 (391.3086276)